scholarly article | Q13442814 |
P356 | DOI | 10.1016/0306-4522(86)90041-2 |
P698 | PubMed publication ID | 2422595 |
P2093 | author name string | Cuello AC | |
Mai JK | |||
Hopf A | |||
Stephens PH | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 709-739 | |
P577 | publication date | 1986-03-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | Substance P in the human brain | |
P478 | volume | 17 |
Q30446663 | "Perestroika" in the basal forebrain: opening the border between neurology and psychiatry |
Q37485071 | 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease |
Q41668119 | Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells |
Q48280824 | An immunohistochemical study of neurotransmitter profiles in developing human visual cortex |
Q49136032 | Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography |
Q46355804 | Asymmetric increase in substance P immunoreactivity in the rat and guinea pig substantia nigra after unilateral neocortical ablation |
Q59449478 | Chapter II Neurobiology and neuropathology of the human hypothalamus |
Q36980707 | Comparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene |
Q38805959 | Corticostriatal circuitry |
Q59544688 | Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans |
Q48598794 | Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS. |
Q42467347 | Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain |
Q48318744 | Differential regulation of substance P and somatostatin in martinotti cells of the developing cat visual cortex |
Q48391416 | Distribution of neurokinin A in the cat diencephalon: An immunocytochemical study |
Q67656953 | Distribution of substance P-like immunoreactive fibres and terminals in the medulla oblongata of the human infant |
Q48136897 | Distribution of substance P-like immunoreactive neurons and terminals throughout the nucleus of the solitary tract in the human brainstem |
Q35162929 | Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers |
Q71726132 | Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens |
Q37698126 | GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen |
Q45295460 | Globus pallidus degeneration and clinicopathological features of Huntington disease |
Q34082836 | Immunocytochemical study of substance P-like cell bodies and fibres in the brain of the rainbow trout, Salmo gairdneri |
Q48237961 | Immunohistochemical characterization of substance P receptor (NK(1)R)-expressing interneurons in the entorhinal cortex. |
Q40848213 | Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system |
Q48126020 | Interaction between substance P and gastrin-releasing peptide on thyrotropin secretion by rat pituitary in vitro |
Q48545415 | Intraventricular Administration of Substance P Induces Unattached Purkinje Cell Dendritic Spines in Rats |
Q34413850 | Involvement of substance P and the NK-1 receptor in human pathology |
Q36875936 | Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain |
Q44258700 | Mapping of alpha-neo-endorphin- and neurokinin B-immunoreactivity in the human brainstem. |
Q24798706 | Mapping of neurokinin-like immunoreactivity in the human brainstem |
Q48973883 | Metabolic activity of the human ventromedial nucleus neurons in relation to sex and ageing |
Q48875017 | Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons |
Q51864098 | Morphologic and immunohistochemical organization of the human habenular complex. |
Q34460547 | Neurobiology and neurochemistry of Rett syndrome |
Q48703592 | Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala |
Q42478068 | Neurochemical heterogeneity of the primate nucleus accumbens |
Q35952741 | Neuropeptides in hypothalamic neuronal disorders |
Q35225841 | Ontogeny of some neuropeptides in the primate brain |
Q48172230 | PE-11, a peptide derived from chromogranin B, in the human brain |
Q31160220 | Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing |
Q69016962 | Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain |
Q48164642 | Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study |
Q48770511 | Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion |
Q73316280 | Quantitative imaging of substance P in the human brain using a brain mapping analyzer |
Q40846734 | Role of central amino acids and peptide-mediated pathways in neurohypophysial hormone release. |
Q42458136 | Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis |
Q34899236 | Sex differences in the neural circuit that mediates female sexual receptivity |
Q48151676 | Subgroups of parkinsonian patients differentiated by peptidergic immunostaining of caudate nucleus biopsies |
Q35337407 | Substance P and neuropsychiatric disorders: an overview |
Q48874876 | Substance P and substance K in the median eminence and paraventricular nucleus of the rat hypothalamus |
Q48788439 | Substance P and substance K in the rat hypothalamus following monosodium glutamate lesions of the arcuate nucleus |
Q34973822 | Substance P immunoreactivity exhibits frequent colocalization with kisspeptin and neurokinin B in the human infundibular region |
Q42487386 | Substance P immunoreactivity in Rett syndrome |
Q43590011 | Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons |
Q34409278 | Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential |
Q59328812 | Substance P- and tyrosine hydroxylase- containing neurom in the human dorsal motor nucleus of the vagus nerve |
Q42455135 | Substance P-containing pyramidal neurons in the cat somatic sensory cortex |
Q44800050 | Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex |
Q30470007 | Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders |
Q41209277 | Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases |
Q35109191 | The Autocrine/Paracrine Regulation of Thyrotropin Secretion |
Q48868681 | The distribution of noradrenaline, serotonin and gamma-aminobutyric acid in the monkey nucleus accumbens |
Q34259043 | The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders |
Q38208768 | The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P. |
Q29619828 | The reward circuit: linking primate anatomy and human imaging |
Q38928744 | The role of the human globus pallidus in Huntington's disease. |
Q38486467 | The striatal mosaic in primates: Patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum |
Q61449190 | Toward a Common Terminology for the Thalamus |
Q27322756 | Ultra-High Field MRI Post Mortem Structural Connectivity of the Human Subthalamic Nucleus, Substantia Nigra, and Globus Pallidus |
Q48772014 | Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain |
Search more.